Vertex stock falls after pain drug VX-993 fails Phase 2 trial, despite better-than-expected Q2 earnings and strong cystic ...

Analysts are estimating that Helmerich & Payne will report an earnings per share (EPS) of $0.21. The announcement from ...

Analysts have provided Horace Mann Educators with 3 ratings, resulting in a consensus rating of Buy. The average one-year ...

Analysts are estimating that Jack In The Box will report an earnings per share (EPS) of $1.16. Investors in Jack In The Box ...

Axon Enterprise Inc. (NASDAQ: AXON) stock surged on strong Q2 results and raised revenue guidance. Multiple analysts raised ...

BioNTech SE BNTX -0.15% Get Free Report reported a narrower loss for the second quarter on Monday. The company posted a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, versus a loss of ...

ZetaChain's (CRYPTO: ZETA) latest integration with the Sui (CRYPTO: SUI) blockchain could bring real capital flows and ...

The company reported a quarterly revenue growth of 6% year-on-year (Y/Y) to $372.06 million, compared to the analyst consensus estimate of $370.23 million. The Israel-based contract chipmaker's ...

Rocket Lab shares dipped 1.41% to $43.88 despite a flawless Electron mission, Stifel's buy rating (raising its target to $55) ...

BioMarin beats Q2 expectations on strong enzyme therapy sales and raises full-year earnings and revenue guidance amid continued Voxzogo growth.

Now Frank is on the hook for a car payment of $1,100 a month. And things got worse fast: “He’s going away for a very long ...

Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter ...